Nutritional & Herbal Immune Support
Compounded Prescription Support for Immune Dysregulation
Mast Cell Activation Syndrome and Compounded Formulations
Mast Cell Activation Syndrome (MCAS) involves inappropriate release of inflammatory mediators from mast cells. Management may involve mast cell stabilizers, antihistamines, leukotriene pathway modifiers, and other prescriber-directed therapies. In some cases, compounded formulations are prepared to adjust strengths, remove problematic excipients, or provide alternative dosage forms based on patient-specific considerations.